Dj. Abraham et al., INTRINSIC ACTIVITY AT THE MOLECULAR-LEVEL - ARIENS,E.J. CONCEPT VISUALIZED, Journal of Molecular Biology, 248(4), 1995, pp. 845-855
The concept of using affinity and intrinsic activity to analyze drug i
nteractions with receptors has had a long history in pharmacological s
tudies. In the simplest case, the biological response will be proporti
onal to the amount of drug bound, i.e. its affinity However, the biolo
gical response is also mediated by the ability of a drug when bound to
exert its maximum effectiveness. This effectiveness is termed the int
rinsic activity Physicochemical processes have been thought to be at t
he basis of intrinsic activity Detailed oxygen and solution binding ex
periments combined with X-ray crystallographic studies on allosteric e
ffecters to hemoglobin demonstrate that these potential drug agents bi
nd at the same site in hemoglobin with similar binding constants yet s
hift the allosteric equilibrium and the oxygen affinity of the T-struc
ture by different degrees. Therefore some of the effecters with simila
r binding affinities for the same site exhibit varying degrees of affe
ctiveness, i.e. they possess different intrinsic activities. The intri
nsic activity of the effector is defined as the ratio of the oxygen af
finity constant to the T-state with drug/oxygen affinity constant to t
he T-state without drug (K-T+drug)/(K-Tcontrol) The source of the intr
insic activity appears to be the ability of the effecters to interact
with key residues such as Lys99 alpha at the binding site. These resul
ts suggest a general molecular mechanism for allosteric effector modul
ation of hemoglobin function that might be of use in other allosteric
enzyme systems.